These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies. Pallayova M; Taheri S Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857 [TBL] [Abstract][Full Text] [Related]
10. The role of incretin hormones and glucagon in patients with liver disease. Junker AE Dan Med J; 2017 May; 64(5):. PubMed ID: 28552096 [TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic steatohepatitis in children. Nanda K Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336 [TBL] [Abstract][Full Text] [Related]
12. From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis. Moore JB Proc Nutr Soc; 2019 Aug; 78(3):290-304. PubMed ID: 30924429 [TBL] [Abstract][Full Text] [Related]
13. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Vernon G; Baranova A; Younossi ZM Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design. Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352 [TBL] [Abstract][Full Text] [Related]